Saturday 19 November 2011

FDA yanks approval of Avastin for treating breast cancer

To the despair of some critically ill patients, a federal agency on Friday revoked its approval of Avastin for treating breast cancer after determining the widely used drug developed by South San Francisco-based Genentech fails to help patients live longer and causes life-threatening side effects ...


Related News:-

  • www.tcrp.in


  • DCGI's consulting DTAB for banning controversial drugs may only help delay decision: Experts 2010-01-19: Union govt earmarks Rs.450 cr for 2 bio-cluster projects in NCR, Bangalore
  • Topic Galleries -- baltimoresun.com


  • Topic galleries provide easy access to stories and photos about people, places, organizations, events and subjects of interest to you. They bring together rich multimedia ...
  • Enbrel


  • Enbrel This page contains recent news articles, when available, and an overview of Enbrel but does not offer medical advice. You should contact your physician with regard to ...

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...